CLL Society’s Official Statement on Boosters for CLL (Chronic Lymphocytic Leukemia) Patients
This content was current as of the date it was released. In science and medicine, information is constantly changing and may become out-of-date as new data emerge.
CLL Society to Present Innovative Telemedicine Platform Study at American Society of Hematology Annual Conference
CLL Society co-founder and Medical Director Dr. Brian Koffman will present research results of the society’s innovative telemedicine program at the prestigious American Society of Hematology annual meeting in early December. The program provides patients and caregivers access to HIPPA-compliant second opinions from renowned specialists in chronic lymphocytic leukemia (CLL), the most common adult blood cancer.